Factors Influencing Adherence to Anti-Tb Drugs in Sunyani Municipality, Ghana; A Cross-Sectional Study Facteurs influençant l'observance thérapeutique des médicaments antituberculeux dans la municipalité deSunyani, au Ghana : une étude transversale
Main Article Content
Abstract
Background: A large portion of the global population has been infected with Mycobacterium tuberculosis, but most eliminate it without developing tuberculosis. About 50 % of TB patients fail to adhere to treatment, leading to incomplete therapy, drug resistance, prolonged infectiousness, relapse, and death. Nonadherence contributes to multidrug-resistant TB.
Objective: This study identified factors that influence adherence to anti-TB drugs in the Sunyani Municipality.
Methodology: A quantitative, descriptive cross-sectional design was used. The study population included TB patients aged ≥ 18 years who had been on treatment for at least one month across three selected hospitals. Data were collected from 157 participants using an interviewer-led structured questionnaire, with adherence measured via the 8-item Morisky Medication Adherence Scale. Data were entered into Excel, cleaned, and analyzed in Stata 15. Descriptive and inferential statistics were performed, using Chi-square and Fisher's exact tests to identify associations, and logistic regression to determine the strength of significant factors. Statistical significance was set at p ≤ 0.05.
Results: Majority of respondents were male (65.6 %). Adherence to anti-TB drugs was 53.5 %. Bivariate analysis found associations between adherence and gender (p=0.020), social support (p=0.030), primary caregiver (p=0.002), beliefs about TB (p=0.013), knowledge about TB (p=0.003), and accessibility to healthcare facilities (p=0.001). In multiple logistic regression, gender and healthcare facility access were independently associated with adherence (aOR=2.19, p=0.039 and aOR=4.07, p=0.030, respectively). Males had 2.19 times higher odds of adherence than females. Participants with ready access to a healthcare facility had 4.07 times higher odds of adherence than those without.
Conclusion: Adherence to anti-TB drugs was relatively low at 53.5 %. Male gender and ready access to healthcare facilities significantly predicted better adherence. Interventions to improve adherence in the Sunyani Municipality should be strengthened, with further research needed to explain thegender disparity in adherence behavior.
Résumé
Contexte : Une grande partie de la population mondiale a été infectée par Mycobacterium tuberculosis, mais la plupart des personnes l'éliminent sans développer de tuberculose. Environ 50 % des patients atteints de tuberculose n'adhèrent pas au traitement, ce qui entraîne une thérapie incomplète, une résistance aux médicaments, une contagiosité prolongée, des rechutes et des décès. La non-observance du traitement contribue à l'émergence de la tuberculose multirésistante.
Objectif : Cette étude a identifié les facteurs qui influencent l'observance des traitements antituberculeux dans la municipalité de Sunyani.
Méthodologie : Une étude transversale quantitative et descriptive a été menée. La population étudiée comprenait des patients atteints de tuberculose âgés de ≥ 18 ans ou plus, sous traitement depuis au moins un mois, répartis dans trois hôpitaux sélectionnés. Les données ont été recueillies auprès de 157 participants à l'aide d'un questionnaire structuré administré par un enquêteur. L'observance thérapeutique a été mesurée grâce à l'échelle d'observance médicamenteuse de Morisky à 8 items. Des analyses statistiques descriptives et inférentielles ont été réalisées, à l'aide des tests du chi carré et le test exact de Fisher pour identifier les associations, et une régression logistique pour déterminer la force des facteurs significatifs. Le seuil de signification statistique a été fixé à p ≤ 0,05.
Résultats : La majorité des répondants étaient des hommes (65,6 %). L'observance du traitement avec les médicaments antituberculeux était de 53,5 %. L'analyse bivariée a révélé des associations entre l'observance et le sexe (p = 0,020), le soutien social (p = 0,030), la présence d'un aidant principal (p = 0,002), les croyances relatives à la tuberculose (p = 0,013), les connaissances sur la tuberculose (p = 0,003) et l'accès aux soins dans les établissements de santé (p = 0,001). Dans le cadre d'une régression logistique multiple, le sexe et l'accès aux soins dans les établissements de santé étaient indépendamment associés à l'observance (aOR = 2,19, p = 0,039 et aOR = 4,07, p = 0,030, respectivement). Les hommes avaient 2,19 fois plus de chances d'observer leur traitement que les femmes. Les participants ayant facilement accès à un établissement de santé avaient 4,07 fois plus de chances d'observer leur traitement que ceux qui n'y avaient pas accès.
Conclusion : l'observance thérapeutique des médicaments antituberculeux était relativement faible (53,5 %). Le sexe masculin et un accès facile aux soins dans les établissements de santé prédisaient significativement une meilleure observance. Les interventions visant à améliorer l'observance ans a municipalité de Sunyani devraientêtre renforcées, et des recherches supplémentaires sont nécessaires pour expliquer les disparités entre les sexes dans le comportement d'observance.
Downloads
Article Details
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
Share
References
1.WHO. Global Tuberculosis Report (2025). World Health Organization 1-98. Available from: http://www.who.int/tb/publications/global_report/en/index.html
2.Adebisi YA, Agumage I, Sylvanus TD, Nawaila IJ, Ekwere WA, Nasiru M, Okon EE, Ekpenyong AM, Iii DELP (2019). Burden of Tuberculosis and Challenges Facing Its Eradication in West Africa. International Journal of Infections diseases 6(3).
3.Okhovat-Isfahani B, Bitaraf S, Mansournia MA, Doosti-Irani A (2019). Inequality in the global incidence and prevalence of tuberculosis(TB) and TB/HIV according to the human development index. Medical Journal of the Islamic Republic of Iran. 33:45. https://doi.org/10.47176/mjiri.33.45
4.Appiah MA, Arthur JA, Gborgblorvor D, Asampong E, Kye-duodu G, Kamau EM, Dako-Gyeke P (2023). Barriers to tuberculosis treatment adherence in high-burden tuberculosis settings in Ashanti region ,Ghana?: a qualitative study from patient ' s perspective. BMC Publich Health 23(1):1317. doi: 10.1186/s12889-023-16259-6. PMID: 37430295; PMCID: PMC10332032.
5. WHO. Country Disease Outlook, Ghana (2023). World Health Organization African Region (August):66-67
6. Dogah E, Aviisah M, Kuatewo DAM, Kpene GE, Lokpo SY, Edziah FS (2021). Factors Influencing Adherence to Tuberculosis Treatment in the Ketu North District of the Volta Region, Ghana. Tuberculosis Research and Treatment. Mar 30;1-6.
7. Ubajaka CF, Azuike EC, Ugoji JO, Nwibo OE, Ejiofor OC, Modebe IA, Umeh UM (2015). Adherence to Drug Medications amongst Tuberculosis Patients in a Tertiary Health Institution in South East Nigeria. International Journal of Clinical Medicine 06(06):399-406.
8. Gebremariam RB, Wolde M, Beyene A (2021). Determinants of adherence to anti-TB treatment and associated factors among adult TB patients in Gondar ity administration, Northwest, Ethiopia: based on health belief model perspective. Journal of Health, Population and Nutrition 40(1):1-10. Available from: https://doi.org/10.1186/s41043-021-00275-6
9. Nkansah M, Singh B, Feglo P (2026). Drug resistance patterns and associated risk factors in pulmonary tuberculosis patients from selected hospitals in Ghana. BMC Infectious Diseases 26(239). Available from: https://doi.org/10.1186/s12879-025-12503-z
10. Boakye-Appiah JK, Steinmetz AR, Pupulampu P, Ofori-Yirenkyi S, Tetteh I, Frimpong M, Oppong P, Opare-Sem O, Norman BR, Stienstra Y, van der Werf TS, Wansbrough-Jones M, Bonsu F, Obeng- Baah J, Phillips RO (2016). High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana. International Journal of Mycobacteriology 5(2):226-230. Available from: http://dx.doi.org/10.1016/j.ijmyco.2016.02.004
11. Ba-iredire E, Avoka JA, Attombo EJ, Agboli E (2025). Prevalence and factors influencing drug-resistant tuberculosis in four regions of Ghana. PLoS One 1- 14. Available from: https://doi.org/10.1371/journal.pone.0331958
12. Danso E, Addo IY, Ampomah IG (2015). Patients' Compliance with Tuberculosis Medication in Ghana: Evidence from a Periurban Community. Advances in Public Health 1-6.
13. Garbrah, B.G., Abebrese, J. & Owusu-Marfo, J (2024). Factors associated with tuberculosis treatment adherence among tuberculosis patients in the Kumasi metropolis in the Ashanti Region of Ghana; A cross-sectional study. Journal of Public Health (Berlin) 32:2353-2364. https://doi.org/10.1007/s10389-023-02002-3
14. Morisky DE, Ang A, Krousel-Wood M, Ward HJ (2008). Predictive validity of a medication adherence measure in an outpatient setting. Journal of Clinical Hypertension 10(5):348-354.
15. Bress AP, Bellows BK, King JB, Hess R, Beddhu S, Zhang Z, Berlowitz DR, Conroy MB, Fine L, Oparil S, Morisky DE, Kazis LE, Ruiz-Negrón N, Powell J, Tamariz L, Whittle J, Wright JT Jr, Supiano MA, Cheung AK, Weintraub WS, Moran AE (2017). Cost- Effectiveness of Intensive versus Standard Blood-Pressure Control. The New England Journal of Medicine 377(8):745-755.
16. Berlowitz DR, Foy CG, Kazis LE, Bolin LP, Conroy MB, Fitzpatrick P, Gure TR, Kimmel PL, Kirchner K, Morisky DE, Newman J, Olney C, Oparil S, Pajewski NM, Powell J, Ramsey T, Simmons DL, Snyder J, Supiano MA, Weiner DE, Whittle J (2017). Effect of Intensive Blood-Pressure Treatment on Patient- Reported Outcomes. The New England Journal of Medicine 377(8):733-744.
17. Nirmal G, Karki RR, Khanam R (2021). Knowledge on tuberculosis and utilization of DOTS service by tuberculosis patients in Lalitpur District, Nepal. PLoS One 1-14. https://doi.org/10.1371/journal.pone.0245686
18. Dorji T, Tshering T, Wangdi K (2020). Assessment of knowledge , attitude and practice on tuberculosis among teacher trainees of Samtse College of Education. PLoS One 357: 1-16. https://doi.org/10.1371/journal.pone.0241923
19. Kwakye, G (2019). Factors Influencing Clients Adherence to Tuberculosis Treatment In Birim outh. European Journal of Hospital Pharmacy
185(39): 335-346. http://ugspace.ug.edu.gh
20. Wanyama, BA (2017). Determinants of TB treatment adherence among patients on anti-TB treatment in Tororo District, Uganda. University of the Western Cape, January, 1-166. http://etd.uwc.ac.za/
21. Shiferaw DA, Mekonnen HS, Abate AT (2019). House- hold contact tuberculosis screening adherence and associated factors among tuberculosis patients attending at health facilities in Gondar town, northwest, Ethiopia. BMC Infectious Diseases 19(1):1-8.
22. Mekonnen HS, Gebrie MH, Eyasu KH, Gelagay AA (2017). Drug adherence for antihypertensive medications and its determinants among adult hypertensive patients attending in chronic clinics of referral hospitals in Northwest Ethiopia. BMC Pharmacology and Toxicology 18(1):1-10.
23. Bea S, Lee H, Kim JH, Jang SH, Son H (2021). Adherence and Associated Factors of Treatment Regimen in Drug-Susceptible Tuberculosis Patients 12(March):1-9.
24. Fang XH, Shen HH, Hu WQ, Xu QQ, Jun L, Zhang ZP, Kan XH, Ma DC, Wu GC (2019). Prevalence of and factors influencing anti-tuberculosis treatment non- adherence among patients with pulmonary tuberculosis: A cross-sectional study in Anhui Province, Eastern China. Medical Science Monitor 25:1928-1935.
25. Sazali MF, Rahim SSSA, Mohammad AH, Kadir F, Payus AO, Avoi R, Jeffree MS, Omar A, Ibrahim MY, Atil A, Tuah NM, Dapari R, Lansing MG, Rahim AAA, Azhar ZI (2023). Improving Tuberculosis Medication Adherence: The Potential of Integrating Digital Technology and Health Belief Model. Tuberculosis and Respiratory Diseases (Seoul) 86(2):82-93.
26. Adisa R, Ayandokun TT, Ige OM (2021). Knowledge about tuberculosis, treatment adherence and outcome among ambulatory patients with drug-sensitive tuberculosis in two directly-observed treatment centres in Southwest Nigeria. BMC PublicHealth. Dec 1;21(1).
27. Grigoryan Z, McPherson R, Harutyunyan T, Truzyan N, Sahakyan S (2022). Factors Influencing Treatment Adherence Among Drug-Sensitive Tuberculosis (DS- TB) Patients in Armenia: A Qualitative Study. Patient Preference and Adherence 16:2399-2408. to anti-TB drugs
28. Ali AOA, Prins MH (2020). Patient Characteristics Associated with Non-Adherence to Tuberculosis Treatment: A Systematic Review. Journal of Tuberculosis Research 08(02):73-92. 29. Gashu KD, Gelaye KA, Tilahun B (2021). Adherence toTB treatment remains low during continuation phase among adult patients in Northwest Ethiopia. BMC Infectious Diseases 1-10.
30. Nezenega ZS, Perimal-lewis L, Maeder AJ (2020). Factors influencing patient adherence to tuberculosis treatment in ethiopia: A literature review. International Journal of Environmental Research and Public Health 17: 1-12.
31. Kigozi G, Heunis C, Chikobvu P, Botha S, van Rensburg D (2017). Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa. International Journal Infectious Diseases 54:95-102.
32. Bello SI, Itiola OA (2010). Drug adherence amongst tuberculosis patients in the. African Journal of Pharmacy and Pharmacology 4(3):109-114. Available from: http://www.academicjournals.org/ajpp
33. Anaam MS, Mohamed Ibrahim MI, Al Serouri AW, Aldobhani A (2013). Factors affecting patients' compliance to anti-tuberculosis treatment in Yemen. Journal of Pharmaceutical Health Services Research 4(2):115-122.
34. Agyare SA, Osei FA, Odoom SF, Mensah NK, Amanor E, Martyn-Dickens C, Owusu-Ansah M, Mohammed A, Yeboah EO (2021). Treatment Outcomes and Associated Factors in Tuberculosis Patients at Atwima Nwabiagya District, Ashanti Region, Ghana: A Ten- Year Retrospective Study. Tuberculosis Research and Treatment 1-9.